222 related articles for article (PubMed ID: 26918042)
41. Can peripheral blood monocyte percentage and lymphocyte monocyte ratio at diagnosis predict survival in pediatric neuroblastoma patients?
Yalçın K; Tüysüz G; Küpesiz FT; Bozkurt S; Küpesiz A; Güler E
Turk J Pediatr; 2021; 63(5):884-892. PubMed ID: 34738370
[TBL] [Abstract][Full Text] [Related]
42. Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer.
Goto W; Kashiwagi S; Asano Y; Takada K; Takahashi K; Hatano T; Takashima T; Tomita S; Motomura H; Hirakawa K; Ohira M
BMC Cancer; 2018 Nov; 18(1):1137. PubMed ID: 30453914
[TBL] [Abstract][Full Text] [Related]
43. Infused autograft lymphocyte to monocyte ratio predicts survival in classical Hodgkin lymphoma.
Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Hogan WJ; Markovic SN
J Blood Med; 2015; 6():45-53. PubMed ID: 25674021
[TBL] [Abstract][Full Text] [Related]
44. The lymphocyte-to-monocyte ratio could predict the efficacy of PD-1 inhibitors in patients with advanced cancer.
Xiao L; Li L; Chen G; Zhang Y; Gao Q
Transl Cancer Res; 2020 Jul; 9(7):4111-4120. PubMed ID: 35117780
[TBL] [Abstract][Full Text] [Related]
45. Pre-operative lymphocyte-to-monocyte ratio as a predictor of overall survival in patients suffering from osteosarcoma.
Liu T; Fang XC; Ding Z; Sun ZG; Sun LM; Wang YL
FEBS Open Bio; 2015; 5():682-7. PubMed ID: 26380812
[TBL] [Abstract][Full Text] [Related]
46. Low preoperative lymphocyte to monocyte ratio predicts poor cancer-specific survival in patients with esophageal squamous cell carcinoma.
Huang Y; Feng JF
Onco Targets Ther; 2015; 8():137-45. PubMed ID: 25609981
[TBL] [Abstract][Full Text] [Related]
47. Elevated peripheral blood lymphocyte-to-monocyte ratio predicts a favorable prognosis in the patients with metastatic nasopharyngeal carcinoma.
Jiang R; Cai XY; Yang ZH; Yan Y; Zou X; Guo L; Sun R; Luo DH; Chen QY; Huang PY; Xiang YQ; Lu X; Wang L; Xia WX; Mai HQ; Chen MY
Chin J Cancer; 2015 Jun; 34(6):237-46. PubMed ID: 26067059
[TBL] [Abstract][Full Text] [Related]
48. Lymphocyte-to-monocyte ratio effectively predicts survival outcome of patients with obstructive colorectal cancer.
Chen XQ; Xue CR; Hou P; Lin BQ; Zhang JR
World J Gastroenterol; 2019 Sep; 25(33):4970-4984. PubMed ID: 31543687
[TBL] [Abstract][Full Text] [Related]
49. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with small cell lung cancer.
Go SI; Kim RB; Song HN; Kang MH; Lee US; Choi HJ; Lee SJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Kim SH; Kang JH; Ling H; Lee GW
Med Oncol; 2014 Dec; 31(12):323. PubMed ID: 25417187
[TBL] [Abstract][Full Text] [Related]
50. Pretreatment Lymphocyte to Monocyte Ratio is an Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma.
Gu L; Ma X; Xie Y; Li H; Wang L; Chen L; Zhao W; Zhang Y; Zhang X
Clin Genitourin Cancer; 2017 Jun; 15(3):e369-e377. PubMed ID: 28038932
[TBL] [Abstract][Full Text] [Related]
51. Lymphocyte-to-monocyte ratio before chemoradiotherapy represents a prognostic predictor for locally advanced rectal cancer.
Deng YX; Lin JZ; Peng JH; Zhao YJ; Sui QQ; Wu XJ; Lu ZH; Gao YH; Zeng ZF; Pan ZZ
Onco Targets Ther; 2017; 10():5575-5583. PubMed ID: 29200872
[TBL] [Abstract][Full Text] [Related]
52. Prognostic significance of dynamic changes in lymphocyte-to-monocyte ratio in patients with head and neck cancer treated with radiotherapy: results from a large cohort study.
Lin CH; Chou WC; Wu YY; Lin CY; Chang KP; Liao CT; Ho TY; Yeh CM; Liu CJ; Hung SP; Lee CH; Chen PJ; Chou YC; Fan KH; Huang BS; Tung-Chieh Chang J; Wang CC; Tsang NM
Radiother Oncol; 2021 Jan; 154():76-86. PubMed ID: 32941957
[TBL] [Abstract][Full Text] [Related]
53. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancer.
Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Yamazoe S; Kimura K; Toyokawa T; Amano R; Tanaka H; Muguruma K; Hirakawa K
World J Gastroenterol; 2015 Sep; 21(34):9966-73. PubMed ID: 26379401
[TBL] [Abstract][Full Text] [Related]
54. Prognostic significance of the preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer.
Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
Oncol Lett; 2017 Feb; 13(2):1000-1006. PubMed ID: 28356991
[TBL] [Abstract][Full Text] [Related]
55. Peripheral Blood Lymphocyte-to-Monocyte Ratio at Relapse Predicts Outcome for Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in the Rituximab Era.
Katoh D; Ochi Y; Yabushita T; Ono Y; Hiramoto N; Yoshioka S; Yonetani N; Matsushita A; Hashimoto H; Kaji S; Imai Y; Ishikawa T
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):e91-e97. PubMed ID: 28918104
[TBL] [Abstract][Full Text] [Related]
56. The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients.
Jia W; Wu J; Jia H; Yang Y; Zhang X; Chen K; Su F
PLoS One; 2015; 10(11):e0143061. PubMed ID: 26580962
[TBL] [Abstract][Full Text] [Related]
57. Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion.
Lim JU; Yeo CD; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Lee SH
PLoS One; 2018; 13(7):e0200341. PubMed ID: 30005083
[TBL] [Abstract][Full Text] [Related]
58. Prognostic significance of preoperative inflammatory response biomarkers in patients undergoing curative thoracoscopic esophagectomy for esophageal squamous cell carcinoma.
Hirahara N; Matsubara T; Kawahara D; Nakada S; Ishibashi S; Tajima Y
Eur J Surg Oncol; 2017 Feb; 43(2):493-501. PubMed ID: 28034501
[TBL] [Abstract][Full Text] [Related]
59. Utility of Preoperative Inflammatory Markers to Distinguish Epithelial Ovarian Cancer from Benign Ovarian Masses.
Li L; Tian J; Zhang L; Liu L; Sheng C; Huang Y; Zheng H; Song F; Chen K
J Cancer; 2021; 12(9):2687-2693. PubMed ID: 33854628
[No Abstract] [Full Text] [Related]
60. Peripheral Blood Lymphocyte-to-Monocyte Ratio as a Useful Prognostic Factor in Newly Diagnosed Multiple Myeloma.
Tian Y; Zhang Y; Zhu WQ; Chen XL; Zhou HB; Chen WM
Biomed Res Int; 2018; 2018():9434637. PubMed ID: 30599001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
